The Role of Cardiac Monitoring in COPD Care and Clinical Trials Cardiovascular disease is one of the leading causes of death among COPD patients, who have a two to five times higher risk of ischaemic heart disease, cardiac dysrhythmia, and heart failure. For researchers designing trials involving COPD patients, this increased risk means that monitoring the heart is non-negotiable.